1. Alternative Donor Transplantation—“Mixing and Matching”: the Role of Combined Cord Blood and Haplo-Identical Donor Transplantation (Haplo-Cord SCT) as a Treatment Strategy for Patients Lacking Standard Donors?

   • Hongtao Liu
   • Koen van Besien

   Stem Cell Transplantation (R Maziarz, Section Editor) 10 February 2015 Pages: 1 - 7

2. A Call to Arms: a Critical Need for Interventions to Limit Pulmonary Toxicity in the Stem Cell Transplantation Patient Population

   • Sabarinath Venniyil Radhakrishnan
   • Gerhard C. Hildebrandt

   Stem Cell Transplantation (R Maziarz, Section Editor) 08 February 2015 Pages: 8 - 17

   

3. The Evolving Role of Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia

   • Matthew S. Davids
   • Edwin P. Alyea

   Stem Cell Transplantation (R Maziarz, Section Editor) 15 February 2015 Pages: 18 - 27

   

4. Patient Selection for Allogeneic Hematopoietic Cell Transplantation (HCT): the Evolution of HCT Risk Assessment

   • Lori Muffly

   Stem Cell Transplantation (R Maziarz, Section Editor) 11 December 2014 Pages: 28 - 34

5. Survivorship After Allogeneic Transplantation—Management Recommendations for the Primary Care Provider

   • André Tichelli
   • Alicia Rovó

   Stem Cell Transplantation (R Maziarz, Section Editor) 10 February 2015 Pages: 35 - 44

6. Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?

   • Lara E. Sucheston-Campbell
   • Alyssa Clay
   • Theresa Hahn

   Stem Cell Transplantation (R Maziarz, Section Editor) Open access 21 February 2015 Pages: 45 - 58

   

7. Where Does Allogeneic Stem Cell Transplantation Fit in the Treatment of Chronic Lymphocytic Leukemia?

   • Peter Dreger
   • Emili Montserrat
   • on behalf of the European Society for Blood and Marrow Transplantation (EBMT) and the European Research Initiative on CLL (ERIC)

   Chronic Lymphocytic Leukemias (S O’Brien, Section Editor) 05 February 2015 Pages: 59 - 64